Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.

British consumers can now buy three Mederma scar-care products in the UK via Amazon and Superdrug thanks to a recent launch by France's HRA Pharma. 

GlaxoSmithKline has averted a strike at its sites across the UK after an improved pay offer was accepted by workers.

“If you took all of these markets where people brush their teeth less than one time a day and just moved it to one time a day, you would increase the volume size of the category by 40%,” noted Colgate-Palmolive’s John Faucher in a 19 May presentation at the Goldman Sachs Global Staples Forum.

A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.

Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.

GlaxoSmithKline has averted a strike at its sites across the UK after an improved pay offer was accepted by workers.

Activist investment group Tulipshare’s proposal that J&J fully cease sales of talc-based powders didn’t receive a majority of votes in favor during firm's annual meeting and won’t be forwarded for board’s consideration. Separate proposal for an audit into whether firm marketed products to minority women asbestos concerns was sent to the board.

National Advertising Division, in rare review of an Rx drug firm’s challenge of supplement ad claims, reported Innovix Pharma pulled health claims for OmegaVia brand supplements challenged by Amarin. Innovix prevailed in defending its labeling as accurate and its name as not false advertising.